Back to ARNA Stock Lookup

Arena Pharma (ARNA) – Company Press Releases

Sep 22, 2014 08:00 AM Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
Sep 10, 2014 08:00 AM Lorcaserin HCl Data to be Presented at the American Society of Bariatric Physicians' 64th Annual Obesity & Associated Conditions Symposium
Sep 2, 2014 08:00 AM Arena Pharmaceuticals' APD811 Granted Orphan Drug Status for Pulmonary Arterial Hypertension
Aug 1, 2014 04:30 AM Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results
Jul 30, 2014 08:00 AM Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity
Jul 29, 2014 08:00 AM Eisai and Arena Pharmaceuticals Announce BELVIQ® (lorcaserin HCl) CIV Nominated a Second Time for the Prix Galien Award in the Best Pharmaceutical Agent Category
Jul 25, 2014 08:00 AM Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Friday, August 1
Jul 21, 2014 08:00 AM Arena Pharmaceuticals Enters into Marketing and Supply Agreement for BELVIQ® (lorcaserin HCl) in Israel
Jul 15, 2014 04:31 PM Arena Pharmaceuticals Issued Patent for APD371 by United States Patent and Trademark Office
Jul 10, 2014 08:00 AM Arena Pharmaceuticals Reports that Eisai Completes Planned Increase in Sales Force for BELVIQ® (lorcaserin HCl) CIV

Back to ARNA Stock Lookup